[go: up one dir, main page]

IL131156A0 - 4-Aminoalkyl-1,3-dihydrobenzoimidazol-2-one derivatives their preparation and their use as dopamine autoreceptor (d2) agonists - Google Patents

4-Aminoalkyl-1,3-dihydrobenzoimidazol-2-one derivatives their preparation and their use as dopamine autoreceptor (d2) agonists

Info

Publication number
IL131156A0
IL131156A0 IL13115698A IL13115698A IL131156A0 IL 131156 A0 IL131156 A0 IL 131156A0 IL 13115698 A IL13115698 A IL 13115698A IL 13115698 A IL13115698 A IL 13115698A IL 131156 A0 IL131156 A0 IL 131156A0
Authority
IL
Israel
Prior art keywords
dihydrobenzoimidazol
aminoalkyl
agonists
derivatives
preparation
Prior art date
Application number
IL13115698A
Other languages
English (en)
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of IL131156A0 publication Critical patent/IL131156A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13115698A 1997-02-18 1998-01-13 4-Aminoalkyl-1,3-dihydrobenzoimidazol-2-one derivatives their preparation and their use as dopamine autoreceptor (d2) agonists IL131156A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80187097A 1997-02-18 1997-02-18
PCT/US1998/000623 WO1998035946A1 (en) 1997-02-18 1998-01-13 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists

Publications (1)

Publication Number Publication Date
IL131156A0 true IL131156A0 (en) 2001-01-28

Family

ID=25182225

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13115698A IL131156A0 (en) 1997-02-18 1998-01-13 4-Aminoalkyl-1,3-dihydrobenzoimidazol-2-one derivatives their preparation and their use as dopamine autoreceptor (d2) agonists

Country Status (14)

Country Link
EP (1) EP0964853A1 (es)
JP (1) JP2001511804A (es)
KR (1) KR20000071160A (es)
CN (1) CN1138761C (es)
AR (1) AR011138A1 (es)
AU (1) AU744443B2 (es)
BR (1) BR9807703A (es)
CA (1) CA2278747A1 (es)
HU (1) HUP0001262A3 (es)
IL (1) IL131156A0 (es)
NZ (1) NZ337271A (es)
TW (1) TW383303B (es)
WO (1) WO1998035946A1 (es)
ZA (1) ZA981310B (es)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914003A1 (en) * 1990-11-20 1992-05-20 Astra Pharma Prod Biologically Active Amines
GB9210632D0 (en) * 1992-05-19 1992-07-01 Fisons Plc Compounds
DE69524528T2 (de) * 1994-10-14 2002-08-01 Merck Patent Gmbh ZNS wirksames (R)-(-)-2-[5-(4-Fluorophenyl)-3-pyridylmethylaminomethyl]chroman
IL119483A (en) * 1995-11-06 1999-06-20 American Home Prod 2-(Aminomethyl)-3,4,7,9- tetrahydro- 2H-pyrano-2[3,3-e]indol-8-ones their derivatives and pharmaceutical compositions containing them
EP0923576B1 (en) * 1996-08-27 2002-11-06 Wyeth 4-aminoethoxy-indolone derivatives as dopamine d2 agonists
WO1998008819A1 (en) * 1996-08-27 1998-03-05 American Home Products Corporation 4-aminoethoxy indolone derivatives

Also Published As

Publication number Publication date
HUP0001262A3 (en) 2002-04-29
AU6023498A (en) 1998-09-08
TW383303B (en) 2000-03-01
AU744443B2 (en) 2002-02-21
HUP0001262A2 (hu) 2001-04-28
EP0964853A1 (en) 1999-12-22
WO1998035946A1 (en) 1998-08-20
ZA981310B (en) 1999-08-17
AR011138A1 (es) 2000-08-02
NZ337271A (en) 2001-01-26
JP2001511804A (ja) 2001-08-14
CA2278747A1 (en) 1998-08-20
CN1138761C (zh) 2004-02-18
KR20000071160A (ko) 2000-11-25
CN1252060A (zh) 2000-05-03
BR9807703A (pt) 2000-05-02

Similar Documents

Publication Publication Date Title
IL141479A0 (en) Substituted phenyl derivatives, their preparation and use
HUP9904051A3 (en) 4-hetaroylpyrazol derivatives, preparation and use thereof as herbicides
CZ20011855A3 (cs) Derivát substituovaného benzimidazolu, způsob jeho přípravy a jeho použití
AU6190199A (en) New compounds, their preparation and use
AU6190299A (en) New compounds, their preparation and use
IS5353A (is) Asýl-píperasínil-pýrimídínafleiður, framleiðsla og notkun þeirra sem lyfja
IL138609A0 (en) Antipicornaviral compounds, their preparation and use
HUP0101475A3 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
GB9817235D0 (en) Compound,composition and use
IL135451A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
GB9817236D0 (en) Compound,composition and use
HUP0104510A3 (en) Benzofuran derivatives, their preparation and use
GB9903447D0 (en) Compound, composition and use
AU1937300A (en) Indole derivatives and their use as 5-HT1F agonists
HUP0204572A3 (en) Substituierte bisindolylmaleinimide derivatives, process for their preparation and use and pharmaceutcial compositions containing them
GB9817238D0 (en) Compound,composition and use
PL344978A1 (en) 4,5,6 and 7-indole and indoline derivatives, their preparation and use
GR3035834T3 (en) Benzoxazindione derivatives, process for their preparation and their use
IL131158A0 (en) 4-Aminoalkoxy-1h-benzimidazole derivatives their preparation and their use as dopamine autoreceptor (d2) agonists
IL131156A0 (en) 4-Aminoalkyl-1,3-dihydrobenzoimidazol-2-one derivatives their preparation and their use as dopamine autoreceptor (d2) agonists
IL131157A0 (en) 4-Aminoalkoxy-1,3-dihydrobenzoimidazol-2-thione derivatives their preparation and their use as dopamine autoreceptor (d2) agonists
IL135452A0 (en) 3-amino-3-arylpropan-1-ol derivatives, their preparation and use
AU2883397A (en) 5-alkoxy-tryptamine derivatives, their preparation and their use as 5-ht1d receptor agonists
AU5524400A (en) Novel 6-amino-uracil derivatives, preparation and use thereof
IL149993A0 (en) Novel heteroaryl derivatives, their preparation and use